<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer - Vellayappan, BA - 2017 | Cochrane Library</title> <meta content="Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer - Vellayappan, BA - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010511.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer - Vellayappan, BA - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010511.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010511.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer" name="citation_title"/> <meta content="Balamurugan A Vellayappan" name="citation_author"/> <meta content="National University Hospital" name="citation_author_institution"/> <meta content="vellay@gmail.com" name="citation_author_email"/> <meta content="Yu Yang Soon" name="citation_author"/> <meta content="National University Hospital" name="citation_author_institution"/> <meta content="Geoffrey Y Ku" name="citation_author"/> <meta content="Memorial Sloan‐Kettering Cancer Center" name="citation_author_institution"/> <meta content="Cheng Nang Leong" name="citation_author"/> <meta content="National University Hospital" name="citation_author_institution"/> <meta content="Jiade J Lu" name="citation_author"/> <meta content="Shanghai Proton and Heavy Ion Center (SPHIC)" name="citation_author_institution"/> <meta content="Jeremy CS Tey" name="citation_author"/> <meta content="National University Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD010511.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/08/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010511.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010511.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010511.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Chemoradiotherapy [adverse effects, mortality]; *Esophagectomy [mortality]; Carcinoma [mortality, pathology, surgery, therapy]; Carcinoma, Squamous Cell [mortality, pathology, surgery, *therapy]; Cisplatin; Combined Modality Therapy [adverse effects, methods, mortality]; Deglutition Disorders [therapy]; Esophageal Neoplasms [mortality, pathology, surgery, *therapy]; Fluorouracil [administration &amp; dosage]; Neoplasm Recurrence, Local; Quality of Life; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010511.pub2&amp;doi=10.1002/14651858.CD010511.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="dLyXbLct";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010511\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010511\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ms","hr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010511.pub2",title:"Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer",firstPublishedDate:"Aug 22, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010511.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010511.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010511.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010511.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010511.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010511.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010511.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010511.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010511.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010511.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4092 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010511.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-sec-0087"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-sec-0030"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-sec-0031"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-sec-0057"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-sec-0077"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/appendices#CD010511-sec-0092"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/table_n/CD010511StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/table_n/CD010511StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information#CD010511-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Balamurugan A Vellayappan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information#CD010511-cr-0003">Yu Yang Soon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information#CD010511-cr-0004">Geoffrey Y Ku</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information#CD010511-cr-0005">Cheng Nang Leong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information#CD010511-cr-0006">Jiade J Lu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information#CD010511-cr-0007">Jeremy CS Tey</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information/en#CD010511-sec-0098">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 August 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010511.pub2">https://doi.org/10.1002/14651858.CD010511.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010511-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010511-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010511-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010511-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010511-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010511-abs-0001" lang="en"> <section id="CD010511-sec-0001"> <h3 class="title" id="CD010511-sec-0001">Background</h3> <p>Please see <a href="http://04" target="_blank">Appendix 4</a> for a glossary of terms. </p> <p>The outcome of patients with esophageal cancer is generally poor. Although multimodal therapy is standard, there is conflicting evidence regarding the addition of esophagectomy to chemoradiotherapy. </p> </section> <section id="CD010511-sec-0002"> <h3 class="title" id="CD010511-sec-0002">Objectives</h3> <p>To compare the effectiveness and safety of chemoradiotherapy plus surgery with that of chemoradiotherapy alone in people with nonmetastatic esophageal carcinoma. </p> </section> <section id="CD010511-sec-0003"> <h3 class="title" id="CD010511-sec-0003">Search methods</h3> <p>We performed a computerized search for relevant studies, up to Feburary 2017, on the CENTRAL, MEDLINE, and Embase databases using MeSH headings and keywords. We searched five online databases of clinical trials, handsearched conference proceedings, and screened reference lists of retrieved papers. </p> </section> <section id="CD010511-sec-0004"> <h3 class="title" id="CD010511-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) comparing chemoradiotherapy plus esophagectomy with chemoradiotherapy alone for localized esophageal carcinoma. We excluded RCTs comparing chemotherapy or radiotherapy alone with esophagectomy. </p> </section> <section id="CD010511-sec-0005"> <h3 class="title" id="CD010511-sec-0005">Data collection and analysis</h3> <p>Two authors independently selected studies, extracted data, and assessed risk of bias and the quality of the evidence, using standardized Cochrane methodological procedures. The primary outcome was overall survival (OS), estimated with Hazard Ratio (HR). Secondary outcomes, estimated with risk ratio (RR), were local and distant progression‐free survival (PFS), quality of life (QoL), treatment‐related mortality and morbidity, and use of salvage procedures for dysphagia. Data were analyzed using a random effects model in Review Manager 5.3 software. </p> </section> <section id="CD010511-sec-0006"> <h3 class="title" id="CD010511-sec-0006">Main results</h3> <p>From 2667 references, we identified two randomized studies, in six reports, that included 431 participants. All participants were clinically staged to have at least T3 and/or node positive thoracic esophageal carcinoma, 93% of which was squamous cell histology. The risk of methodological bias of the included studies was low to moderate. </p> <p>High‐quality evidence found the addition of esophagectomy had little or no difference on overall survival (HR 0.99, 95% CI 0.79 to 1.24; P = 0.92; I² = 0%; two trials). Neither study reported PFS, therefore, freedom from loco‐regional relapse was used as a proxy. Moderate‐quality evidence suggested that the addition of esophagectomy probably improved freedom from locoregional relapse (HR 0.55, 95% CI 0.39 to 0.76; P = 0.0004; I² = 0%; two trials), but low‐quality evidence suggested it may increase the risk of treatment‐related mortality (RR 5.11, 95% CI 1.74 to 15.02; P = 0.003; I² = 2%; two trials). </p> <p>The other pre‐specified outcomes (quality of life, treatment‐related toxicity, and use of salvage procedures for dysphagia) were reported by only one study, which found very low‐quality evidence that use of esophagectomy was associated with reduced short‐term QoL (MD 0.93, 95% CI 0.24 to 1.62), and low‐quality evidence that it reduced use of salvage procedures for dysphagia (HR 0.52, 95% CI 0.36 to 0.75). Neither study compared treatment‐related morbidity between treatment groups. </p> </section> <section id="CD010511-sec-0007"> <h3 class="title" id="CD010511-sec-0007">Authors' conclusions</h3> <p>Based on the available evidence, the addition of esophagectomy to chemoradiotherapy in locally advanced esophageal squamous cell carcinoma, provides little or no difference on overall survival, and may be associated with higher treatment‐related mortality. The addition of esophagectomy probably delays locoregional relapse, however, this end point was not well defined in the included studies. It is undetermined whether these results can be applied to the treatment of adenocarcinomas, tumors involving the distal esophagus and gastro‐esophageal junction, and to people with poor response to chemoradiation. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010511-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010511-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010511-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010511-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010511-abs-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010511-abs-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010511-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010511-abs-0003" lang="en"> <h3>The benefits and side effects of adding surgery to chemoradiotherapy for the treatment of esophageal cancer that can be surgically removed </h3> <p><b>Review question</b> </p> <p>Does the addition of surgery to chemoradiotherapy, improve survival in people with resectable esophageal cancer (cancer that can be surgically removed)? </p> <p><b>Background</b> </p> <p>Cancer of the esophagus (muscular tube that leads from the mouth through the throat to the stomach) is a lethal condition. It is usually treated with surgery, radiotherapy, chemotherapy, or a combination of these. It is unclear if adding surgery after chemoradiotherapy (chemotherapy plus radiation) adds any benefit for people with esophageal cancer. </p> <p><b>Study characteristics</b> </p> <p>We included two randomized studies, in six published reports, with 431 participants with locally advanced esophageal cancer. We searched biomedical databases, clinical trial registries, conference proceedings, and reference lists up to 7 February 2017 for studies. </p> <p><b>Quality of the evidence</b> </p> <p>The quality of evidence ranged from very low to high, depending on the outcome being assessed, because the trials were small and at unclear or high risk of bias (a systematic error or deviation from the truth that affects the results, favouring one treatment over another). </p> <p><b>Key results</b> </p> <p>We found evidence that adding surgery reduced the risk of the cancer recurring at the primary site, but did not improve overall survival. Moreover, there were more treatment‐related deaths in the group of participants who underwent surgery. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010511-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010511-sec-0087"></div> <h3 class="title" id="CD010511-sec-0088">Implications for practice</h3> <section id="CD010511-sec-0088"> <p>There is moderate‐quality evidence that adding surgery to chemoradiation probably increases the time to locoregional relapse. However, based on the available evidence, this may be at the cost of increased treatment‐related morality and little or no improvement in overall survival. People who do not respond to chemoradiation, or who have persistent local disease, warrant upfront surgery. In addition, in people where surgery is deferred, they should undergo close surveillance and surgical salvage upon local recurrence. </p> </section> <h3 class="title" id="CD010511-sec-0089">Implications for research</h3> <section id="CD010511-sec-0089"> <p>Large scale randomized studies with homogenous treatment arms, using modern techniques, and including participants with adenocarcinoma histology (which is now the dominant histology in the U.S., Western Europe, and parts of Australasia), may be warranted, to re‐assess the impact of upfront surgery on survival. </p> <p>Furthermore, participant selection using advanced functional imaging (e.g. PET or CT), or predictive biomarkers may help select participant groups who may benefit from upfront surgery after definitive chemoradiation. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010511-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010511-sec-0022"></div> <div class="table" id="CD010511-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer</span></div> <tbody> <tr class="table-header separated"> <td align="left" class="table-header" colspan="6" rowspan="1" valign="top"> <p><b>Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> nonmetastatic esophageal cancer<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> chemoradiotherapy plus surgery<br/> <b>Comparison:</b> chemoradiotherapy alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b> Relative effect (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with chemoradiotherapy alone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with chemoradiotherapy plus surgery</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival<br/> Follow‐up: median 4 to 6 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35.4% to 40.0% at 2 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34.0% to 39.9% at 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 0.99 (95% CI 0.79 to 1.24)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Freedom from locoregional relapse</p> <p>Follow‐up: median 4 to 6 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40.7% to 57.0% at 2 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>64.3% to 66.4% at 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 0.55 (95% CI 0.39 to 0.76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of Life</p> <p>assessed with: Spitzer QoL index</p> <p>Scale: 0 to10</p> <p>Follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>the mean Q0L score was 7.52 points in the chemoradiotherapy alone group</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>the mean QoL score in the chemoradiotherapy plus surgery group was 0.93 points worse (from ‐1.62 worse to ‐0.24 worse) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very Low<sup>2,3,4</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment‐related mortality</p> <p>Follow‐up: median 1 to 3 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1.9 per 100</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9.5 per 100</p> <p>(3.2 to 27.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 5.11<br/> (95% CI 1.74 to 15.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Use of salvage procedures for dysphagia</p> <p>Follow‐up: median 4 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.52 (95% CI 0.36 to 0.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>259</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>HR:</b> Hazard ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to risk of bias (detection bias as investigators were not blinded).<br/> <sup>2</sup> Downgraded one level due to imprecision.<br/> <sup>3</sup> Downgraded two levels due to risk of bias (detection bias as investigators and participants were not blinded). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010511-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010511-sec-0023"></div> <section id="CD010511-sec-0024"> <h3 class="title" id="CD010511-sec-0024">Description of the condition</h3> <p>Esophageal cancer accounted for 16,980 new cancer cases and 15,590 cancer deaths in the United States alone in 2015 (<a href="./references#CD010511-bbs2-0044" title="SiegelRL , MillerKD , JemalA . Cancer statistics, 2015. CA: A Cancer Journal for Clinicians2015;65(1):5‐29. [DOI: 10.3322/caac.21254] ">Siegal 2015</a>). The incidence rate is highest in Southern Africa and Eastern Asia (<a href="./references#CD010511-bbs2-0047" title="TorreLA , SiegelRL , WardEM , JemalA . Global cancer incidence and mortality rates and trends: an update. Cancer Epidemiology, Biomarkers &amp; Prevention2016;25(1):16‐27. ">Torre 2016</a>). </p> <p>Esophageal cancer is usually classified histologically as squamous cell carcinoma (SCC) or adenocarcinoma. Squamous cell carcinoma has been increasing in certain Asian countries, such as Taiwan, and decreasing in Western countries, such as North America. Such trends are likely due to differences in the rates of alcohol consumption and tobacco use (<a href="./references#CD010511-bbs2-0012" title="CookMB , ChowWH , DevesaSS . Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005. British Journal of Cancer2009;101(5):855‐9. [PUBMED: 19672254] ">Cook 2009</a>; <a href="./references#CD010511-bbs2-0031" title="LuCL , LangHC , LuoJC , LiuCC , LinHC , ChangFY , et al. Increasing trend of the incidence of esophageal squamous cell carcinoma but not adenocarcinoma in Taiwan. Cancer Causes and Control2010;21(2):269‐74. [PUBMED: 19866363] ">Lu 2010</a>). Interestingly, incidence rates for adenocarcinoma have been increasing in Western countries, probably due to an increase in the prevalence of obesity (<a href="./references#CD010511-bbs2-0019" title="El‐SeragHB . Time trends of gastroesophageal reflux disease: a systematic review. Clinical Gastroenterology and Hepatology2007;5(1):17‐26. [PUBMED: 17142109] ">El‐Serag 2007</a>; <a href="./references#CD010511-bbs2-0039" title="PostPN , SiersemaPD , VanDekkenH . Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: a nation‐wide registry of pathology reports. Scandinavian Journal of Gastroenterology2007;42(1):17‐22. [PUBMED: 17190757] ">Post 2007</a>). Another important risk factor may be chronic gastroesophageal (GE) reflux disease, which leads to Barrett's esophagus, a pre‐malignant condition associated with lower esophageal and GE junction adenocarcinoma. </p> <p>Esophageal cancer remains an aggressive malignancy, despite current treatment modalities. The Surveillance, Epidemiology and End Results (<a href="http://seer.cancer.gov/statistics/" target="_blank">SEER</a>) registry demonstrated a statistically significant, but modest improvement in the five‐year relative overall survival (OS) from 5% between 1975 and 1977 to 18.5% from 2001 to 2007 (<a href="http://www.cancer.gov" target="_blank">NCI 2011</a>). Survival is dependent on the stage of disease, with five‐year relative OS of 37.3% for localized disease, 18.4% for regional disease, and 3.1% for metastatic disease. Unfortunately, more than half of the people presented with advanced (regional and metastatic) disease at diagnosis (<a href="http://www.cancer.gov" target="_blank">NCI 2011</a>). </p> </section> <section id="CD010511-sec-0025"> <h3 class="title" id="CD010511-sec-0025">Description of the intervention</h3> <p>The National Comprehensive Cancer Network (<a href="http:///www.nccn.org" target="_blank">NCCN</a>) and European Society for Medical Oncology (ESMO) guidelines established a standard of care for medically fit people with resectable disease (<a href="./references#CD010511-bbs2-0030" title="LordickF , MarietteC , HaustermansK , ObermannovaR , ArnoldD , ESMO Guidelines Committee. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow‐up. Annals of Oncology2016;27(Suppl 5):v50‐7. ">Lordick 2016</a>). While surgery alone is appropriate for early‐stage disease (T1N0), combined modality therapy is offered to people with more advanced disease (T2 to T4 and/or node positive disease). Specifically, options include definitive chemoradiotherapy or trimodality treatment (preoperative chemoradiotherapy or chemotherapy followed by surgery; surgery followed by chemoradiotherapy). Treatment options depend on the tumor location, as well as histology. </p> <section id="CD010511-sec-0026"> <h4 class="title">Surgery alone</h4> <p>The type of approach for esophagectomy, such as transhiatal or thoracoabdominal, is dependent on the size, stage, and location of the primary tumor, surgeon's experience, and patient preference. Studies have demonstrated a five‐year survival rate of 20% with surgery alone (<a href="./references#CD010511-bbs2-0006" title="AltorkiN , KentM , FerraraC , PortJ . Three‐field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Annals of Surgery2002;236(2):177‐83. ">Altorki 2002</a>; <a href="./references#CD010511-bbs2-0009" title="BossetJF , GignouxM , TribouletJP , TiretE , MantionG , EliasD , et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous‐cell cancer of the esophagus. New England Journal of Medicine1997;337(3):161‐7. [PUBMED: 9219702] ">Bosset 1997</a>; <a href="./references#CD010511-bbs2-0023" title="HulscherJBF , VanSandickJW , deBoerAG , WijnhovenBP , TijssenJGP , FockensP , et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New England Journal of Medicine2002;347:1662‐9. ">Hulscher 2002</a>; <a href="./references#CD010511-bbs2-0026" title="KelsenDP , GinsbergR , PajakTF , SheahanDG , GundersonL , MortimerJ , et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. New England Journal of Medicine1998;339(27):1979‐84. [PUBMED: 9869669 ] ">Kelsen 1998</a>; <a href="./references#CD010511-bbs2-0037" title="OrringerMB , MarshallB , IannettoniMD . Transhiatal esophagectomy: clinical experience and refinements. Annals of Surgery1999;230:392‐403. ">Orringer 1999</a>). Survival postesophagectomy is not dependent on the type of surgical approaches or histology. Muller and colleagues reviewed the outcomes of various types of esophagectomy and did not find any significant differences in postesophagectomy survival (<a href="./references#CD010511-bbs2-0035" title="MullerJM , ErasmiH , StelznerM , ZierenU , PichlmaierH . Surgical therapy of oesophageal carcinoma. British Journal of Surgery1990;77:845‐57. ">Muller 1990</a>). Salazar and colleagues reported similar cumulative postoperative survival rates for people with SCC and adenocarcinoma (<a href="./references#CD010511-bbs2-0043" title="SalazarJD , DotyJR , LinJW , DykeMC , RobertsJ , HeitmillerES , et al. Does cell type influence post‐esophagectomy survival in patients with esophageal cancer. Diseases of the Esophagus1998;11:168‐71. ">Salazar 1998</a>). </p> </section> <section id="CD010511-sec-0027"> <h4 class="title">Defintive chemoradiotherapy</h4> <p>The Radiation Therapy Oncology Group (RTOG) 85‐01 study demonstrated that concurrent chemoradiotherapy improved OS significantly in people with medically operable SCC when compared with radiotherapy alone (<a href="./references#CD010511-bbs2-0013" title="CooperJS , GuoMD , HerskovicA , MacdonaldJS , MartensonJA , Al‐SarrafM , et al. Chemo‐radiotherapy of locally advanced esophageal cancer: long term follow up of a prospective randomized trial (RTOG 85‐01). JAMA1999;281:1623‐7. ">Cooper 1999</a>). In this study, 121 people were randomized to receive four cycles of cisplatin plus 5‐fluorouracil with concurrent radiotherapy (50 Gy in 25 fractions), or radiotherapy (64 Gy in 32 fractions) alone. About 88% of the participants had SCC. People who received combined modality treatment had a significant improvement in five‐year OS (27% versus 0%) and median survival (14 months versus 9 months) compared with radiotherapy alone. The incidence of local failure (local recurrence or persistent disease) at one year was also lower in the combined modality arm (47% versus 65%). The results of this study have established definitive chemoradiotherapy as the standard of care for people with SCC who are not surgical candidates. </p> </section> <section id="CD010511-sec-0028"> <h4 class="title">Trimodality treatment</h4> <p>Numerous phase II and III studies have compared preoperative chemoradiotherapy followed by surgery versus surgery alone. The use of pre‐ or perioperative chemotherapy and surgery has also been evaluated. One updated meta‐analysis of randomized studies, comparing the efficacy of preoperative chemoradiotherapy or chemotherapy followed by surgery with surgery alone, reported a significant survival benefit with preoperative treatment over surgery alone in people with resectable esophageal carcinoma (<a href="./references#CD010511-bbs2-0045" title="SjoquistKM , BurmeisterBH , SmithersBM , ZalcbergJR , SimesRJ , BarbourA , et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal carcinoma: an updated meta‐analysis. Lancet Oncology2011;12:681‐92. ">Sjoquist 2011</a>). The hazard ratio (HR) for all‐cause mortality for preoperative chemoradiotherapy was 0.78 (95% confidence interval (CI) 0.70 to 0.88, P value &lt; 0.0001), and for preoperative chemotherapy was 0.87 (95% CI 0.79 to 0.96, P = 0.005). Based on their findings, a clear advantage of preoperative chemoradiotherapy over chemotherapy could not be established. Moreover, this meta‐analysis did not directly address the question of definitive versus preoperative chemoradiotherapy. </p> <p>The seminal randomized study that supported the use of surgery plus postoperative chemoradiotherapy is the US Intergroup 0116 study (<a href="./references#CD010511-bbs2-0032" title="MacdonaldJS , SmalleySR , BenedettiJ , HundahlSA , EstesNC , StemmermannGN , et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. New England Journal of Medicine2001;345:725‐30. ">Macdonald 2001</a>). In this study, 556 people with resected adenocarcinoma of the stomach or GE junction were randomized to surgery alone or surgery plus postoperative chemoradiotherapy. Twenty per cent of the participants had a tumor at the esophagogastric junction. People who received postoperative chemoradiotherapy had significant improvement in three‐year survival (50% versus 41%), and median survival (36 months versus 27 months). A major criticism of this study was that 54% of the participants underwent less than a group 1 lymph node dissection (i.e. D1 dissection), raising the possibility that radiation may be compensating for inadequate surgery. Nevertheless, this study suggested that postoperative chemoradiotherapy was a reasonable option for people with GE junction adenocarcinoma. A subsequent randomized study from China investigated the role of perioperative chemoradiotherapy in locally advanced (Stage II to III) thoracic esophageal squamous cell carcinoma (<a href="./references#CD010511-bbs2-0025" title="JinLV , CaoXF , ZhuB , JiL , TaoL , WangDD . Long‐term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. World Journal of Gastroenterology2010;16(13):1649‐54. [DOI: 10.3748/wjg.v16.i13.1649] ">Jin 2010</a>). Two hundred and thirty‐eight participants were randomized into surgery alone (80 participants), preoperative chemoradiotherapy (80 participants), and postoperative chemoradiotherapy (78 participants). Progression‐free survival (PFS) and OS were improved with either preoperative (PFS: Chi² 6.81, P = 0.009; OS: Chi² 7.85, P = 0.005) or postoperative (PFS: Chi² 5.38, P = 0.02; OS: Chi² 5.33 P = 0.021) chemoradiotherapy, compared to surgery alone. There were no significant differences in PFS (Chi² 0.14, P = 0.71) or OS (Chi² 0.46, P = 0.50) between pre‐ and postoperative chemoradiotherapy. </p> <p>Compared to trimodality treatment, the role of definitive chemoradiotherapy alone is uncertain. This is particularly so, given the high local failure rate with chemoradiotherapy, the inability to predict a pathologic complete response even with repeat imaging or endoscopy (or both), and lack of data for non‐surgical management of people with adenocarcinoma. </p> </section> </section> <section id="CD010511-sec-0029"> <h3 class="title" id="CD010511-sec-0029">Why it is important to do this review</h3> <p>The benefits of adding surgery to chemoradiotherapy when compared to chemoradiotherapy alone for nonmetastatic esophageal cancer are unclear. Definitive chemoradiotherapy alone has been shown to provide a five‐year OS in up to 27% of people with SCC (<a href="./references#CD010511-bbs2-0013" title="CooperJS , GuoMD , HerskovicA , MacdonaldJS , MartensonJA , Al‐SarrafM , et al. Chemo‐radiotherapy of locally advanced esophageal cancer: long term follow up of a prospective randomized trial (RTOG 85‐01). JAMA1999;281:1623‐7. ">Cooper 1999</a>). This result is similar to that achieved with preoperative chemoradiotherapy followed by surgery alone (<a href="./references#CD010511-bbs2-0036" title="O'ReillyS , ForastiereAA . Is surgery necessary with multimodality treatment of oesophageal cancer. Annals of Oncology1995;6:519‐22. ">O'Reilly 1995</a>; <a href="./references#CD010511-bbs2-0048" title="UrbaSG , OrringerMB , TurrisiA , IannettoniM , ForastiereA , StrawdermanM . Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. Journal of Clinical Oncology2001;19:305‐13. ">Urba 2001</a>; <a href="./references#CD010511-bbs2-0052" title="WalshTN , NoonanN , HollywoodD , KellyA , KeelingN , HennessyTPJ . A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. New England Journal of Medicine1996;335:462‐7. ">Walsh 1996</a>). There was also no clear consensus from the NCCN guidelines on whether a trimodality approach was preferred over chemoradiotherapy alone, in people with resectable disease (<a href="http://www.nccn.org" target="_blank">www.nccn.org</a>). We were unable to locate any systematic reviews or meta‐analyses that specifically addressed the efficacy of a trimodality approach when compared to chemoradiotherapy alone. </p> <p>However, we did find several narrative reviews that addressed the management of people with locally advanced esophageal cancer (<a href="./references#CD010511-bbs2-0028" title="KuGY , IlsonDH . Preoperative therapy for esophageal cancer. Gastroenterology Clinics of North America2009;38(1):135‐52. ">Ku 2009</a>; <a href="./references#CD010511-bbs2-0033" title="MarietteC , PiessenG , TribouletJP . Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncology2007;8(6):545‐53. ">Mariette 2007</a>; <a href="./references#CD010511-bbs2-0053" title="WolfMC , StahlM , KrauseBJ , BonavinaL , BrunsC , BelkaC , et al. Curative treatment of oesophageal carcinoma: current options and future developments. Radiation Oncology2011;26(6):55. ">Wolf 2011</a>). Most authors concluded that definitive chemoradiotherapy has become a reasonable treatment option, especially for people with SCC. Performing surgery on people who respond to initial chemoradiotherapy may improve local control, but may not clearly impact OS. While the overall conclusion was similar in these studies, they lacked explicit methodology in their review, which limited interpretation of the data and valid conclusions. </p> <p>Hence, we conducted a systematic review and meta‐analysis to compare the efficacy and safety of surgery plus chemoradiotherapy with chemoradiotherapy alone in people with nonmetastatic esophageal cancer. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010511-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010511-sec-0030"></div> <p>To compare the effectiveness and safety of chemoradiotherapy plus surgery with that of chemoradiotherapy alone in people with nonmetastatic esophageal carcinoma, in terms of overall survival (OS), progression‐free survival (PFS), quality–of‐life (QoL), treatment‐related mortality and morbidity, and the use of salvage procedures for dysphagia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010511-sec-0031" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010511-sec-0031"></div> <section id="CD010511-sec-0032"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010511-sec-0033"> <h4 class="title">Types of studies</h4> <p>We only included randomized studies in this review. The nature of the intervention made it difficult for blinding to be part of the study design, and therefore, was not a requirement for study inclusion. We included published and unpublished studies, full articles, and abstracts satisfying the criteria listed below, without any language restriction. </p> </section> <section id="CD010511-sec-0034"> <h4 class="title">Types of participants</h4> <p>People with nonmetastatic carcinoma (stage I to III) of the esophagus, who had been treated with curative intent. </p> </section> <section id="CD010511-sec-0035"> <h4 class="title">Types of interventions</h4> <p>The control arm of the study was chemoradiotherapy alone. The intervention arm was the group that underwent chemoradiotherapy plus surgery. Treatment had to be given with curative intent. The timing of the chemotherapy and radiotherapy could be sequential or concomitant; surgery may have been performed pre‐ or post‐chemoradiotherapy. </p> </section> <section id="CD010511-sec-0036"> <h4 class="title">Types of outcome measures</h4> <section id="CD010511-sec-0037"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome was overall survival (OS) — time from randomization to death from any cause. </p> </section> <section id="CD010511-sec-0038"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010511-list-0001"> <li> <p>Local progression‐free survival (PFS) — time from randomization to disease progression at initially treated site by radiotherapy, or death; </p> </li> <li> <p>Distant PFS — time from randomization to disease progression at sites not treated by radiotherapy, or death; </p> </li> <li> <p>Quality of life (QoL) — measured using a validated scale;</p> </li> <li> <p>Treatment‐related mortality;</p> </li> <li> <p>Treatment‐related toxicity (both acute and chronic). Toxicity resulting from treatment is typically classified as acute (that which occurs within 90 days of treatment) or chronic (that which occurs after 90 days of treatment); </p> </li> <li> <p>Use of salvage procedures for dysphagia.</p> </li> </ul> </p> </section> </section> </section> <section id="CD010511-sec-0039"> <h3 class="title">Search methods for identification of studies</h3> <p>We sought papers in all languages and carried out translations if necessary.</p> <section id="CD010511-sec-0040"> <h4 class="title">Electronic searches</h4> <p>We performed the search for studies with the assistance of the Cochrane Upper Gastrointestinal and Pancreatic Diseases Group. The electronic search strategy searched the following databases from its date of inception to 7 February 2017: </p> <p> <ul id="CD010511-list-0002"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 1) in the Cochrane Library (searched 7 February 2017; <a href="./appendices#CD010511-sec-0094">Appendix 2</a>); </p> </li> <li> <p>MEDLINE OVIDSP (1966 to 7 February 2017; <a href="./appendices#CD010511-sec-0095">Appendix 3</a>); </p> </li> <li> <p>Embase OVIDSP (1988 to 7 February 2017; <a href="./appendices#CD010511-sec-0096">Appendix 4</a>). </p> </li> </ul> </p> <p>We used a search strategy to identify randomized controlled studies performed in humans. We used MeSH headings, subject headings, and additional free‐text words. </p> <section id="CD010511-sec-0041"> <h5 class="title">Unpublished and grey literature</h5> <p>We identified prospective and ongoing studies by searching the prospective study registers (February 2017): </p> <p> <ul id="CD010511-list-0003"> <li> <p>International Standard Randomized Controlled Trial Number Registry (<a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a>); </p> </li> <li> <p>US National Institutes of Health (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>); </p> </li> <li> <p>U.S. National Cancer Institute (<a href="http://www.cancer.gov/clinicaltrials/search" target="_blank">www.cancer.gov/clinicaltrials/search</a>); </p> </li> <li> <p>International Clinical Trials Registry Platform (<a href="http://www.who.int/trialsearch" target="_blank">www.who.int/trialsearch</a>); </p> </li> <li> <p>Australian New Zealand Clinical Trials Registry (<a href="http://www.anzctr.org.au" target="_blank">www.anzctr.org.au</a>). </p> </li> </ul> </p> </section> </section> <section id="CD010511-sec-0042"> <h4 class="title">Searching other resources</h4> <section id="CD010511-sec-0043"> <h5 class="title">Handsearching</h5> <p>We handsearched the citation lists of included studies, key textbooks, and previous systematic reviews, and contacted experts in the field to identify further reports of studies. We handsearched reports of conferences in the following sources: </p> <p> <ul id="CD010511-list-0004"> <li> <p>annual meeting of the American Society of Clinical Oncology (2006 to 2016);</p> </li> <li> <p>annual meeting of the American Society for Therapeutic Radiology and Oncology (2006 to 2016); </p> </li> <li> <p>annual meeting of the European Society of Medical Oncology (2006 to 2016);</p> </li> <li> <p>annual Gastrointestinal Cancers Symposium (2006 to 2016).</p> </li> </ul> </p> </section> </section> </section> <section id="CD010511-sec-0044"> <h3 class="title" id="CD010511-sec-0044">Data collection and analysis</h3> <section id="CD010511-sec-0045"> <h4 class="title">Selection of studies</h4> <p>We downloaded all titles and abstracts obtained by electronic searches to a reference management database (Microsoft Excel) and removed duplicates. Four review authors (BAV, YYS, CNL, JCST) independently reviewed the remaining titles and abstracts. They excluded studies that clearly did not meet the inclusion criteria. We obtained full‐text articles of the remaining articles, and four review authors independently determined the eligibility of the retrieved papers. </p> <p>We resolved disagreements by consensus, or by consulting a fifth review author (JJL) if necessary. We documented reasons for exclusion during this process. We did not blind the review authors to the source of the document for article selection or data extraction. </p> </section> <section id="CD010511-sec-0046"> <h4 class="title">Data extraction and management</h4> <p>Four review authors (BAV, YYS, CNL, JCST) independently extracted data on characteristics of participants and interventions, risk of bias, duration of follow‐up, outcomes and deviations from the protocol to a data abstraction form especially designed for the review. We resolved differences between review authors by discussion or by consulting with a fifth review author if necessary. </p> <p>We extracted the following participant data: age, gender, performance status, clinical pretreatment staging (American Joint Committee on Cancer), location of primary tumor (upper, middle, or lower third, or GE junction), histopathological subtype (SCC versus adenocarcinoma), and pathological staging (if available). If documented, we noted modalities used for pretreatment clinical staging, such as barium studies, endoscopy, endoscopic ultrasound, computed tomography, and positron emission tomography. </p> <p>We extracted the following data on types of intervention:</p> <p> <ul id="CD010511-list-0005"> <li> <p>radiotherapy: the total dose and dose fractionation, treatment target volume, beam arrangement, beam energy, modality (photons, electrons, or both), treatment planning (two‐dimensional, three‐dimensional), treatment delivery (conventional, intensity modulated, or brachytherapy), and compliance to the recommended protocol; </p> </li> <li> <p>chemotherapy: chemotherapeutic agents, biologics, schedule, route of administration, dose intensity, and compliance to the recommended protocol. </p> </li> </ul> </p> <p>The type of surgery was to have a curative intent, and consist of esophagectomy to resect all gross and microscopic disease. We documented the type of surgery (transhiatal or transthoracic, two‐ or three‐staged resection). </p> <p>We extracted these data for outcomes:</p> <p> <ul id="CD010511-list-0006"> <li> <p>For time‐to‐event (OS and PFS) data, we extracted the log of the hazard ratio (log (HR)) and its standard error; if these were not reported, we attempted to estimate the log (HR) and its standard error using the methods from Parmar (<a href="./references#CD010511-bbs2-0038" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815‐34. ">Parmar 1998</a>). </p> </li> <li> <p>For dichotomous outcomes (e.g. adverse events or deaths, if it was not possible to use an HR), we extracted the number of participants in each treatment arm who experienced the outcome of interest, and the number of participants originally randomized, in order to estimate a risk ratio (RR). </p> </li> <li> <p>For continuous outcomes (e.g. QoL measures), we extracted the final value and standard deviation of the outcome of interest, and the number of participants assessed at the end point in each treatment arm at the end of follow‐up, in order to estimate the mean difference between treatment arms and its standard deviation. </p> </li> </ul> </p> <p>We extracted both unadjusted and adjusted statistics. We used the data extracted in an intention‐to‐treat analysis, in which participants were analyzed in the groups to which they were assigned. We noted the time points at which outcomes were reported. </p> </section> <section id="CD010511-sec-0047"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Four review authors (BAV, YYS, CNL, JCST) independently used the 'Risk of bias' tool to assess the risk of bias for each study, using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010583.pub3/full#CD010583-bbs2-0051" target="_blank">Higgins 2011</a>). They resolved disputes by consensus, and consulted with a fifth author (LLJ) if necessary. We assessed the risk of bias according to the following domains: </p> <p> <ul id="CD010511-list-0007"> <li> <p>random sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding of participants and personnel;</p> </li> <li> <p>blinding of outcome assessment;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting;</p> </li> <li> <p>other bias.</p> </li> </ul> </p> <p>We graded each potential source of bias as high, low, or unclear risk, and provided a quote from the study report, together with a justification for our judgement, in the 'Risk of bias' table. We summarized the 'Risk of bias' judgements across different studies for each of the domains listed in a 'Risk of bias' summary table (<a href="#CD010511-fig-0001">Figure 1</a>). We interpreted the results of meta‐analyses with respect to the risk of overall bias. </p> <div class="figure" id="CD010511-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010511-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010511-sec-0048"> <h5 class="title">Assessment of bias in conducting the systematic review</h5> <p>We conducted the review according to the published protocol, and reported any deviations from it in the 'Differences between protocol and review' section of the systematic review (<a href="./references#CD010511-bbs2-0050" title="VellayappanBA , SoonYY , KuGY , LeongCN , LuJJ , TeyJCS . Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer. Cochrane Database of Systematic Reviews2013, Issue 5. [DOI: 10.1002/14651858.CD010511] ">Vellayappan 2013</a>). </p> </section> </section> <section id="CD010511-sec-0049"> <h4 class="title">Measures of treatment effect</h4> <p>We used the following measures of the effect of treatment:</p> <p> <ul id="CD010511-list-0008"> <li> <p>for time‐to‐event data, we used hazard ratio (HR), if possible;</p> </li> <li> <p>for dichotomous outcomes, we used the risk ratio (RR);</p> </li> <li> <p>for continuous outcomes, we used the mean difference (MD) between treatment arms.</p> </li> </ul> </p> </section> <section id="CD010511-sec-0050"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual participant. We did not find any cross‐over or cluster‐randomized studies. </p> </section> <section id="CD010511-sec-0051"> <h4 class="title">Dealing with missing data</h4> <p>We were not able to contact the study corresponding authors to obtain missing numerical outcome data. We did not impute any missing data. </p> </section> <section id="CD010511-sec-0052"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed heterogeneity between studies by visually inspecting the forest plots (<a href="./references#CD010511-bbs2-0029" title="L'AbbéKA , DetskyAS , O'RourkeK . Meta‐analysis in clinical research. Annals of Internal Medicine1987;107(2):224‐33. ">L'Abbé 1987</a>), estimating the percentage heterogeneity between studies that could not be attributed to sampling variation (<a href="./references#CD010511-bbs2-0022" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. British Medical Journal2003;327(7414):557‐60. ">Higgins 2003</a>), formally applying a statistical test of significance of the heterogeneity (<a href="./references#CD010511-bbs2-0017" title="DeeksJJ . Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. British Medical Journal2001;323(7305):157‐62. ">Deeks 2001</a>), and if possible, by conducting a subgroup analysis. </p> </section> <section id="CD010511-sec-0053"> <h4 class="title">Assessment of reporting biases</h4> <p>Given that we only included two studies, we did not perform a funnel plot assessment.</p> </section> <section id="CD010511-sec-0054"> <h4 class="title">Data synthesis</h4> <p>If sufficient studies were available, we had planned to pool their data in a meta‐analysis. For time‐to‐event data, we pooled HRs using the generic inverse variance function in RevMan 5 (<a href="./references#CD010511-bbs2-0041" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). For dichotomous outcomes, we calculated a pooled RR. For continuous outcomes, we calculated a pooled mean difference between the two arms at the end of follow‐up, if all studies measured the outcome on the same scale. If different scales were used, used a standardized mean difference. </p> <p>If any studies had multiple treatment groups, we divided the 'shared' comparison group into the number of treatment groups, and treated comparisons between each treatment group and the split comparison group as independent comparisons. </p> <p>We used a random‐effects model with inverse variance weighting for all meta‐analyses (<a href="./references#CD010511-bbs2-0018" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. ">DerSimonian 1986</a>). If possible, we synthesized studies making different comparisons using the methods of Bucher (<a href="./references#CD010511-bbs2-0010" title="BucherHC , GuyattGH , GriffithLE , WalterSD . The results of direct and indirect treatment comparisons in meta‐analysis of randomized controlled trials. Journal of Clinical Epidemiology1997;50(6):683‐91. ">Bucher 1997</a>). </p> </section> <section id="CD010511-sec-0055"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had planned to perform subgroup analysis, grouping the studies by:</p> <p> <ol id="CD010511-list-0009"> <li> <p>concomitant versus sequential chemoradiotherapy;</p> </li> <li> <p>use of targeted therapies (e.g. cetuximab, transtuzumab, and bevacizumab) versus none;</p> </li> <li> <p>type of chemotherapy used (5‐fluorouracil‐based versus cisplatin‐based versus others);</p> </li> <li> <p>histological subtype (SCC versus adenocarcinoma);</p> </li> <li> <p>type of surgery (transhiatal versus transthoracic versus two‐ or three‐stage resections);</p> </li> <li> <p>type of radiation delivery techniques (intensity modulated versus conventional versus brachytherapy); </p> </li> <li> <p>sequencing of intervention in the experimental arm (chemoradiotherapy followed by surgery versus surgery followed by chemoradiotherapy). </p> </li> </ol> </p> <p>We considered factors such as age, clinical staging of esophageal cancer, radiation dose, length of follow‐up, and adjusted and unadjusted analysis in interpretation of heterogeneity. </p> </section> <section id="CD010511-sec-0056"> <h4 class="title">Sensitivity analysis</h4> <p>We had planned to perform sensitivity analysis for the following:</p> <p> <ol id="CD010511-list-0010"> <li> <p>exclusion of studies at high risk of bias;</p> </li> <li> <p>using a fixed‐effect model in place of a random‐effects model.</p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010511-sec-0057" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010511-sec-0057"></div> <section id="CD010511-sec-0058"> <h3 class="title">Description of studies</h3> <section id="CD010511-sec-0059"> <h4 class="title">Results of the search</h4> <p>We identified 2665 records from the search results, and two records from other sources. Once we removed duplicates, we screened 2532 titles and abstracts, excluding 2523 that were obviously not eligible. We obtained the full‐text copy of nine reports and included two randomized controlled studies (<a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a>; <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a>), in six reports (<a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a>; <a href="./references#CD010511-bbs2-0008" title="BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. ">Bonnetain 2006</a>; <a href="./references#CD010511-bbs2-0011" title="BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. ">Burtin 2008</a>; <a href="./references#CD010511-bbs2-0015" title="CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. ">Crehange 2007</a>; <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a>; <a href="./references#CD010511-bbs2-0051" title="VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Vincent 2015</a>), which included 431 participants (<a href="#CD010511-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD010511-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="PRISMA flow diagram." data-id="CD010511-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow diagram.</p> </div> </div> </div> </section> <section id="CD010511-sec-0060"> <h4 class="title">Included studies</h4> <p>Both included studies were published as full journal articles (<a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a>; <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a>). Sample size in the included studies ranged from 172 to 259. Of the 431 included participants, only 29 had adenocarcinoma histology; the remainder had squamous cell cancer. </p> <p><a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> included participants with operable T3N0 thoracic esophageal cancer. There was no restriction for histology or tumor location. All registered participants (N = 444) received induction chemoradiation, however, only participants who showed objective response were randomized (N = 259). </p> <p>Chemotherapy consisted of fluorouracil 800 mg/m² and cisplatin 15 mg/m², given on days one to five, every three weeks. All participants received two cycles prior to randomization; the non‐surgical arm received three more cycles, together with radiation. </p> <p>Radiotherapy was given by conventional fraction or split‐course, until January 1999, when the split‐course arm was discontinued due to inferior results. Radiotherapy volumes included the gross tumor and lymph nodes, with a 3 cm superior‐inferior margin, and 2 cm axial margin. Split‐course radiotherapy was delivered in daily fractions of 3 Gy, in two sequences of five days each (15 Gy each, two weeks apart) prior to randomization, and one sequence after (total 45 Gy). Conventional radiotherapy was delivered to 46 Gy (2 Gy per fraction, five fractions per week) prior to randomization, and 20 Gy after (total 66 Gy). </p> <p>Surgery was performed between days 50 and 60 in the surgical arm, however, no particular type of surgery was recommended. </p> <p>The primary outcome was overall survival; secondary outcomes included duration of hospital stay, quality of life, type of recurrence, and procedures against dysphagia. The primary and selected secondary outcomes were reported in <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a>. Quality of life outcomes were reported in <a href="./references#CD010511-bbs2-0008" title="BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. ">Bonnetain 2006</a>. The results of split‐course versus conventionally‐fractionation were reported in <a href="./references#CD010511-bbs2-0015" title="CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. ">Crehange 2007</a>. Outcome of the registered, but non‐randomized, participants were published by <a href="./references#CD010511-bbs2-0051" title="VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Vincent 2015</a> </p> <p><a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> included locally advanced (T3 to T4, and/or node positive) squamous cell cancers of the upper or mid‐thoracic esophagus. Participants were randomized to induction chemotherapy followed by chemoradiotherapy and surgery versus induction chemotherapy followed by chemoradiotherapy alone. Induction chemotherapy, in both arms, consisted of 3 cycles of bolus flurouracil 500 mg/m², leucovorin 300 mg/m², etoposide 100 mg/m², and cisplatin 30 mg/m² on days one to three, every three weeks. </p> <p>The surgical arm received chemoradiotherapy consisting of cisplatin 50 mg/m² on days two to eight, and etoposide 80 mg/m² on days three to five with 40 Gy of radiation (2 Gy per fraction, over four weeks). The volume of irradiation, included the gross tumor with 5 cm superior‐inferior margin and 2 cm axial margin, as well as the supraclavicular, infraclavicular, and lower cervical nodal regions. This was followed by esophagectomy, two weeks later, involving a right thoracic and abdominal approach (e.g. Ivor‐Lewis procedure) and excision of para‐esophageal, paracardial, left gastric, and celiac lymph nodes (two‐field lymphadenectomy). </p> <p>Participants in the non‐surgical arm were treated with chemoradiotherapy involving the same chemotherapeutic agents and radiation volumes (to 40 Gy). This was followed by a sequential radiation boost. For T4 or obstructing T3 tumors, the gross tumor with a 2 cm superior‐inferior margin and 1 cm axial margin (CTV boost) was treated with 50 Gy, followed by a hyperfractionated boost to 65 Gy (1.5 Gy twice a day, six hours apart, over one week). Non‐obstructing tumors were treated with 60 Gy (CTV boost), followed by two fractions of high‐dose rate brachytherapy boost (4 Gy to 5 mm depth). </p> <p>The primary outcome was overall survival. Secondary outcomes, although not stated explicitly, were assumed to be local progression‐free survival, and treatment‐related mortality. </p> <p>We extracted time‐to‐event data for OS (primary outcome) from both studies. However, secondary outcomes were inconsistently reported, therefore, were only combined where adequate information was available (<a href="#CD010511-sec-0068">Effects of interventions</a>). </p> </section> <section id="CD010511-sec-0061"> <h4 class="title">Excluded studies</h4> <p>We excluded <a href="./references#CD010511-bbs2-0003" title="ISRCTN89052791 . Feasibility trial of chemoradiation or surgery for oesophageal cancer [Oesophageal squamous cell cancer: chemoradiotherapy versus chemotherapy and surgery ‐ a feasibility study]. isrctn.com/ISRCTN89052791 (first received 28 May 2010). [DOI: 10.1186/ISRCTN89052791; EudraCT number 2009‐013877‐16] ">ISRCTN 89052791</a> after review of the study protocol, as the study arms were not in line with our inclusion criteria. This is an ongoing randomized controlled study in esophageal squamous cell cancer, between induction chemotherapy followed by chemoradiotherapy versus surgery. </p> <p>We excluded <a href="./references#CD010511-bbs2-0004" title="NomuraM , KatoK , MizusawaJ , KataokaK , AndoN , MuroK , et al. Comparison between NAC‐S and CRT in overall survival for patients with esophageal squamous cell carcinoma (JCOG1406‐A). Annals of Oncology2015;26 (suppl 7):vii79. [DOI: 10.1093/annonc/mdv471.01] ">Nomura 2015</a>, which is available only in abstract form. This study is a secondary analysis from two randomised controlled studies. The authors compared neoadjuvant chemotherapy followed by surgery to definitive chemoradiotherapy. This study was excluded as randomization was not performed between chemoradiotherapy plus surgery versus chemoradiotherapy alone. </p> <p>We excluded <a href="./references#CD010511-bbs2-0005" title="WangH , RyuJ , GandaraD , BoldR , UrayamaS , TanakaM , et al. A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. Journal of Thoracic Oncology2007;2(2):153‐7. ">Wang 2007</a>, as a process of randomization was not described. Participants were prospectively assigned to neo‐adjuvant chemoradiotherapy, followed by surgery or definitive chemoradiotherapy, followed by consolidation chemotherapy in a non‐randomized fashion. </p> </section> </section> <section id="CD010511-sec-0062"> <h3 class="title">Risk of bias in included studies</h3> <p>We have summarized the risk of bias of the included studies under <a href="./references#CD010511-sec-0101" title="">Characteristics of included studies</a> and <a href="#CD010511-fig-0001">Figure 1</a>. </p> <section id="CD010511-sec-0063"> <h4 class="title">Allocation</h4> <p>The risk of bias in random sequence generation was low in both studies. <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> used a minimization algorithm, whereas <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> used computer‐generated randomization. The risk of bias from allocation concealment was also low in both studies, as they were performed centrally. </p> </section> <section id="CD010511-sec-0064"> <h4 class="title">Blinding</h4> <p>Blinding of participants and personnel was only reported by <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a>. This was an unblinded study, and risk of bias from lack of blinding was high for subjective outcomes, such such as local progression‐free survival and treatment‐related mortality, and low for objective outcomes, such as overall survival. <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> did not describe blinding, so the risk of bias is unclear. Similar to the other study, it is expected that risk of bias would be low for objective outcomes (OS) and high for subjective outcomes (such as quality of life, treatment‐related morbidity, and salvage procedures for dysphagia). </p> </section> <section id="CD010511-sec-0065"> <h4 class="title">Incomplete outcome data</h4> <p>The risk of bias from incomplete outcome data was low for both studies. Neither of the included studies had missing data. Both studies followed an intention‐to‐treat principle in the analysis of survival data. </p> </section> <section id="CD010511-sec-0066"> <h4 class="title">Selective reporting</h4> <p>Risk of bias from selective reporting was low in both studies. <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> reported on the pre‐specified primary outcome (OS), and <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> reported on the pre‐specified primary outcome (OS), and secondary outcomes (duration of hospital stay, quality of life, type of recurrence, and procedures against dysphagia). </p> </section> <section id="CD010511-sec-0067"> <h4 class="title">Other potential sources of bias</h4> <p>We did not find any other potential sources of bias in the included studies. Although a funnel plot was initially planned to examine possible publication bias, due to the small number of included studies, a funnel plot analysis was deemed not useful and therefore, not performed. </p> </section> </section> <section id="CD010511-sec-0068"> <h3 class="title" id="CD010511-sec-0068">Effects of interventions</h3> <p>See: <a href="./full#CD010511-tbl-0001"><b>Summary of findings for the main comparison</b> Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer</a> </p> <section id="CD010511-sec-0069"> <h4 class="title">Overall survival</h4> <p>Overall survival was reported in both the included studies (N = 431; <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a>; <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a>). We used HRs as published, or estimated indirectly from published data, for the calculation of summary statistics. The data appeared homogenous (Chi² = 0.18; P = 0.67; I² = 0%). Pooled data showed little or no difference with the addition of esophagectomy (HR 0.99, 95% confidence interval (CI) 0.79 to 1.24; <a href="./references#CD010511-fig-0003" title="">Analysis 1.1</a>). </p> </section> <section id="CD010511-sec-0070"> <h4 class="title">Progression‐free survival (PFS)</h4> <section id="CD010511-sec-0071"> <h5 class="title">Local PFS</h5> <p>We had defined local progression‐free survival as a secondary outcome in the initial protocol, but neither of the studies reported these data. <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> reported higher locoregional relapse without esophagectomy (HR 1.63, 95% CI 1.04 to 2.55, P = 0.03). <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> reported freedom from local progression favouring esophagectomy (HR 2.1, 95% CI 1.3 to 3.5, P = 0.003). </p> <p>We pooled the data from the two studies (N = 431) and found an improved freedom from locoregional relapse favouring esophagectomy (HR 0.55, 95% CI 0.39 to 0.76; <a href="./references#CD010511-fig-0004" title="">Analysis 1.2</a>). The data appeared homogenous (Chi² = 0.5; P = 0.48; I² = 0%). </p> </section> <section id="CD010511-sec-0072"> <h5 class="title">Distant PFS</h5> <p>This outcome was reported by neither study, and could not be included in a summary statistic calculation. </p> <p><a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> reported a two‐year metastatic probability of 39.1% (SE 5.3) for trimodality therapy and 29% (SE 4.7; P = 0.24) for chemoradiation alone. </p> </section> </section> <section id="CD010511-sec-0073"> <h4 class="title">Quality of life</h4> <p>Quality of life (QoL) was only reported by the FFCD 9102 study (<a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a>). As such, a pooled estimate could not be estimated. In this study, QoL was assessed using the Spitzer QoL index (scored 0 to10), where a higher score indicated a worsening of quality of life. At three‐month follow‐up, only 165 participants had reported QoL scores. Mean difference was worse with trimodality therapy (MD ‐0.93, 95% CI ‐1.62 to ‐0.24; <a href="./references#CD010511-fig-0005" title="">Analysis 1.3</a>). However, subsequent follow‐up did not show any difference between treatment groups (P = 0.26). </p> </section> <section id="CD010511-sec-0074"> <h4 class="title">Treatment‐related mortality</h4> <p>Death due to acute treatment toxicities in both arms were analyzed. This may be classified as grade 5 toxicity, according to the Common Toxicity Criteria for Adverse Events (<a href="./references#CD010511-bbs2-0016" title="Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). 2006 August. ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf (accessed 8 April 2013). ">CTCAE 2006</a>). Perioperative mortality (within 90 days of surgery) was also analyzed under this outcome. </p> <p>Both studies reported this outcome,allowing us to obtain a pooled estimate (N = 431; <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a>; <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a>). The pooled estimate for treatment‐related mortality favoured chemoradiation alone (RR 5.11, 95% CI 1.74 to 15.02; P = 0.003; <a href="./references#CD010511-fig-0006" title="">Analysis 1.4</a>). The data appeared homogenous (Chi² = 1.02; P = 0.31; I² = 2%). </p> </section> <section id="CD010511-sec-0075"> <h4 class="title">Treatment‐related toxicity (acute or chronic)</h4> <p>Toxicity was reported according to the organ systems, and was to be graded according to the intensity of these symptoms. We considered grade 3 and grade 4 toxicities to be severe, and grouped them together. Grade 1 and grade 2 toxicities, if reported, were considered mild (<a href="./references#CD010511-bbs2-0014" title="CoxJD , StetzJ , PajakTF . Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). International Journal of Radiation Oncology, Biology, Physics1995;30(5):1341‐6. ">Cox 1995</a>). Acute and chronic treatment‐related toxicities were analyzed separately. </p> <p>Treatment‐related toxicity was not reported uniformly, and we were unable to combine data in a meta‐analysis. <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> reported acute toxicity after induction chemotherapy, prior to starting chemoradiation. The data on acute toxicity for the individual arms were not presented, and we assumed them to be equal, since identical induction chemotherapy was used for both arms. <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> only presented the incidence of acute toxicity (Grade 3/4) for the chemoradiation arm, as a per‐protocol analysis, and made no comparison with surgery. </p> </section> <section id="CD010511-sec-0076"> <h4 class="title">Use of salvage procedures for dysphagia</h4> <p>This outcome was measured quantitatively to objectively determine the difference between the two groups. Procedures may have included balloon dilation, endoscopic stent insertion, laser debulking of tumor, or tube insertion for enteral nutrition. The outcome was only reported by <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a>. A higher proportion of participants undergoing chemoradiotherapy alone required salvage procedures, either dilation or stent placement, for dysphagia (46.2% versus 24%; P &lt; 0.001), with a RR of 0.52 (95% CI 0.36 to 0.75; <a href="./references#CD010511-fig-0007" title="">Analysis 1.5</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010511-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010511-sec-0077"></div> <section id="CD010511-sec-0078"> <h3 class="title" id="CD010511-sec-0078">Summary of main results</h3> <p>Moderate‐quality evidence found that the addition of esophagectomy to chemoradiotherapy probably improved freedom from locoregional relapse. However, low‐quality evidence found there may be increased treatment‐related mortality, and high‐quality evidence found little or no improvement in overall survival (OS). The impact of esophagectomy on quality of life (QoL), treatment‐related morbidity, and use of salvage procedures for dysphagia was only reported by one study, and hence, remains undetermined. </p> </section> <section id="CD010511-sec-0079"> <h3 class="title" id="CD010511-sec-0079">Overall completeness and applicability of evidence</h3> <p>Despite our systematic and extensive search, we only found two eligible studies to include in the meta‐analysis. From the standpoint of the individual studies, both were only powered to show equivalence, and therefore, any difference in survival may have been deemed not significant. A meta‐analysis provides the ideal statistical tool to increase the power of these comparisons. </p> <p>We judged that the included studies provided sufficient evidence to draw reliable conclusions for overall survival, freedom from locoregional relapse, and treatment‐related mortality. The other outcomes of interest, which were determined a priori, were only reported by one of the two studies (<a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a>). </p> <section id="CD010511-sec-0080"> <h4 class="title">Stage and location of the disease</h4> <p>Multimodal treatment is generally considered necessary for advanced esophageal cancers. No restrictions were placed on stage during our selection of studies. However, it is important to note that these studies included only locally advanced, resectable, cancers and therefore, the applicability should be restricted to this group i.e. T3 to T4, node positive, or both. <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> used both endoscopic ultrasound and computed tomography (CT), whereas <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> relied solely on CT. With regards to T classification, it is possible that a portion of participants were incorrectly‐staged, as CT alone has been shown to be a poor assessor for depth of tumor infiltration (<a href="./references#CD010511-bbs2-0027" title="KimTJ , KimHY , LeeKW , KimMS . Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. RadioGraphics2009;29:403‐21. ">Kim 2009</a>). It remains unclear if the inclusion of a minority of participants with potentially Stages I or II disease would have changed our findings. <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> only included participants with upper and middle esophageal tumors, whereas <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> included all thoracic esophageal tumors. It is unclear how many participants with distal esophageal cancers were included in the latter study, although most squamous cell carcinomas occur in the proximal two‐thirds of the esophagus. As such, these results may not be applicable to distal esophageal and gastroesophageal junction tumors. </p> </section> <section id="CD010511-sec-0081"> <h4 class="title">Effect of histology</h4> <p>There were no restrictions imposed during the search for the studies. However, <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> included only squamous cell carcinoma (SCC) participants and <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> included participants with both SCC and a minority with adenocarcinoma. Overall, 93% of the included participants had squamous cell carcinoma (SCC). It is widely regarded that SCC and adenocarcinoma are considered two separate disease entities, with individual treatment strategies. Therefore, these results should not be applied to people with adenocarcinomas. </p> </section> <section id="CD010511-sec-0082"> <h4 class="title">Responders versus non‐responders</h4> <p>For ethical reasons, <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> only randomized participants who responded to induction chemoradiation. In a recent publication by Vincent and colleagues, the non‐responding participants were reported to have much poorer outcomes; however, the addition of salvage surgery in these participants improved OS (hazard ratio (HR) 0.39, 95% confidence interval (CI) 0.25 to 0.61, P &lt; 0.0001; <a href="./references#CD010511-bbs2-0051" title="VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Vincent 2015</a>). <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> randomized all participants, regardless of their response to induction multi‐agent chemotherapy. However, subgroup analysis corroborated the findings that participants who responsed to induction therapy fared better. These results should not be applied to people who do not respond to induction chemoradiation, i.e. those who had progressive or residual primary tumors. Salvage surgery remains a strong consideration for such people. </p> </section> <section id="CD010511-sec-0083"> <h4 class="title">Chemotherapy and radiotherapy dose and design</h4> <p>A landmark practice changing study (CROSS) published impressive results for the use of neoadjuvant chemoradiotherapy prior to surgery (<a href="./references#CD010511-bbs2-0049" title="VanHagenP , HulshofMCCM , VanLanschotJJB , SteyerbergEW , VanBerge HenegouwenMI , WijnhovenBPL , et al. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer. New England Journal of Medicine2012;366:2074‐84. ">Van Hagen 2012</a>). Many centers have adopted this regimen of weekly carboplatin and paclitaxel with a reduced dose of radiotherapy (41.4 Gy in 23 fractions) prior to surgery. However, for people who are treated with chemoradiotherapy alone, the standard of care remains 50 Gy with platinum and flurouracil‐based chemotherapy, based on the INT 0123 study (<a href="./references#CD010511-bbs2-0034" title="MinskyBD , PajakTF , GinsbergRJ , PisanskyTM , MartensonJ , KomakiR , et al. INT 0123 (Radiation Therapy Oncology Group 94‐05) phase III trial of combined‐modality therapy for esophageal cancer: high‐dose versus standard‐dose radiation therapy. Journal of Clinical Oncology2002;20:1167‐74. ">Minsky 2002</a>). This study was closed early due to mortalities in the dose‐escalated arm (64 Gy). </p> <p><a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> used different radiotherapy regimens in both intervention groups. Participants undergoing surgery had 40 Gy of external beam radiotherapy, whereas participants who received chemoradiation alone, received a total dose of 65 Gy, or more. Notably, all participants in the chemoradiation arm received a coned‐down boost, either with hyper‐fractionated external beam radiotherapy (70%) or high‐dose rate brachytherapy (30%). <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> allowed for both conventionally fractioned radiotherapy and split‐course radiotherapy. However, the split‐course strategy was disallowed midway due to an increased number of deaths. Like <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a>, participants in the surgical arm received chemoradiation (46 Gy), while participants treated with chemoradiation alone received an additional 20 Gy (total 66 Gy). Based on our findings, the addition of surgery did not confer a survival benefit compared to high‐dose chemoradiotherapy alone (more than 65 Gy). However, it remains unclear if surgery may have conferred a survival advantage compared to standard dose chemoradiotherapy alone (50 Gy). </p> <p>Considering that all participants in the <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> study received induction multi‐agent chemotherapy, which in itself has been shown to reduce mortality by 13% (HR 0.87, 95% CI 0.79 to 0.96; <a href="./references#CD010511-bbs2-0045" title="SjoquistKM , BurmeisterBH , SmithersBM , ZalcbergJR , SimesRJ , BarbourA , et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal carcinoma: an updated meta‐analysis. Lancet Oncology2011;12:681‐92. ">Sjoquist 2011</a>), these results may not be applicable to people treated without induction therapy. </p> </section> </section> <section id="CD010511-sec-0084"> <h3 class="title" id="CD010511-sec-0084">Quality of the evidence</h3> <p>We assessed the quality of the evidence for all reported outcomes, including those whose results could not be pooled. </p> <p>We determined the quality of evidence using the guideline development tool developed by the GRADE Working Group (<a href="./references#CD010511-bbs2-0021" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 1 Jun 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro 2015</a>; <a href="./references#CD010511-bbs2-0042" title="RyanR , HillS . How to GRADE the quality of the evidence. Cochrane Consumers and Communication Group cccrg.cochrane.org/author‐resources (accessed 10 December 2016). ">Ryan 2016</a>) </p> <p>Overall survival (two studies): high‐quality evidence. Absence of blinding is unlikely to have influenced this objective outcome. </p> <p>Freedom from locoregional relapse (two studies): moderate‐quality evidence. Downgraded one level due to risk of bias from the absence of blinding. </p> <p>Treatment‐related mortality (two studies): low‐quality evidence. Downgraded one level due to risk of bias from the absence of blinding and imprecision (large confidence interval). </p> <p>Quality of life (one study): very low‐quality evidence. Downgraded two levels due to risk of bias (absence of blinding and loss to follow‐up), downgraded one level due to imprecision (small effect size with overlapping confidence interval) and publication bias. </p> <p>Use of salvage procedures (one study): low‐quality evidence. Downgraded one level due to risk of bias from absence of blinding, imprecision and publication bias. </p> <p>Quality of evidence for treatment‐related toxicity could not be judged as it was reported by neither study. </p> <p>Please refer to <a href="./full#CD010511-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> <section id="CD010511-sec-0085"> <h3 class="title" id="CD010511-sec-0085">Potential biases in the review process</h3> <p>The strengths of this review are that it addresses a clinically relevant and pragmatic question. In addition, this is the first published quantitative review for this specific question </p> <p>A limitation of this review was that we used published results rather than individually updated patient data (IPD). Although these results may overestimate the benefits of additional upfront surgery, it is unlikely that an IPD meta‐analysis would alter the conclusions. This stands to reason, as the effects of upfront surgery on locoregional control and treatment‐related mortality are likely to remain significant, whereas the effects on OS are likely to remain non‐significant. </p> <p>We did not perform a funnel‐plot analysis, as we only identified two studies. Although publication bias may exist, it is unlikely that a large unpublished randomized controlled study exists that would alter our findings. For the same reasons of limited studies, sensitivity and subgroup analysis (as stated in the protocol) were not performed, as they would not have been meaningful. </p> <p>We had not specified, a priori, a subgroup analysis of outcomes between responders and non‐responders to induction treatment. <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> did not randomize participants who failed to respond to induction chemoradiotherapy, and <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> did not provide sufficient information on non‐responders. As such, a quantitative subgroup analysis could not be performed. </p> <p>As mentioned above, both studies were in concordance that non‐responding participants had inferior survival outcomes. <a href="./references#CD010511-bbs2-0051" title="VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Vincent 2015</a> suggested that the survival of non‐responders from the FFCD 9102 study who underwent upfront surgery, was comparable to that of responders having surgery in the randomized arms (median survival 17.3 to 17.7 months). This corroborated with information provided by Stahl’s commentary, where a salvage esophagectomy improved the survival in non‐responders. </p> <p>Another limitation of this study was the inability to summarize the data on local and distant progression‐free survival using the Kaplan‐Meier method, as stated in the protocol. <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a> reported two‐year freedom from local progression, whereas <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> reported two‐year recurrence probability and locoregional relapses. Deviating from the protocol, we combined the available data to formulate a hazard ratio for freedom from locoregional relapse. Although not stated a priori, this provided a close and reliable estimate of local progression‐free survival. </p> <p>A further limitation was the heterogeneity in reporting outcomes, such as distant progression‐free survival, treatment‐related morbidity, use of salvage procedures, and QoL. We thought these outcomes were clinically relevant, so we included them in our protocol. However, only <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> reported on them, so we were unable to perform quantitative analyses. </p> </section> <section id="CD010511-sec-0086"> <h3 class="title" id="CD010511-sec-0086">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD010511-bbs2-0007" title="BestLMJ , MughalM , GurusamyKS . Non‐surgical versus surgical treatment for oesophageal cancer. Cochrane Database of Systematic Reviews2016, Issue 3. [DOI: 10.1002/14651858.CD011498.pub2] ">Best 2016</a> performed a similar systematic review comparing the benefits and harms of non‐surgical treatment with surgical treatment approaches for esophageal cancer. Besides including randomized studies of chemoradiotherapy, with or without esophagectomy, <a href="./references#CD010511-bbs2-0007" title="BestLMJ , MughalM , GurusamyKS . Non‐surgical versus surgical treatment for oesophageal cancer. Cochrane Database of Systematic Reviews2016, Issue 3. [DOI: 10.1002/14651858.CD011498.pub2] ">Best 2016</a> also included randomized studies that compared radiotherapy or chemoradiotherapy with esophagectomy alone. <a href="./references#CD010511-bbs2-0007" title="BestLMJ , MughalM , GurusamyKS . Non‐surgical versus surgical treatment for oesophageal cancer. Cochrane Database of Systematic Reviews2016, Issue 3. [DOI: 10.1002/14651858.CD011498.pub2] ">Best 2016</a> performed a subgroup analysis that pooled the overall survival results of <a href="./references#CD010511-bbs2-0001" title="BedenneL , MichelP , BouchéO , MilanC , MarietteC , ConroyT , et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. Journal of Clinical Oncology2007;25(10):1160‐8. BonnetainF , BouchéO , MichelP , MarietteC , ConroyT , PezetD , et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Annals of Oncology2006;17(5):827‐34. BurtinP , BouchéO , GiovanniniM , PelletierM , ConroyT , RugetO et. al . Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Federation Francophone de Cancerologie Digestive. Gastroenterologie Clinique et Biologique2008;32:213‐20. CrehangeG , MaingonP , PeignauxK , NguyenTD , MirabelX , MarchalC , et al. Phase III trial of protracted compared with split‐course chemoradiation for esophageal carcinoma: Fédération Francophone de Cancérologie Digestive 9102. Journal of Clinical Oncology2007;25(31):4895‐901. VincentJ , MarietteC , PezetD , HuetE , BonnetainF , BouchéO , et al. Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non‐randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation alone. European Journal of Cancer2015;51(13):1683‐93. ">Bedenne 2007</a> and <a href="./references#CD010511-bbs2-0002" title="StahlM , StuschkeM , LehmannN , MeyerHJ , WalzMK , SeeberS , et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. Journal of Clinical Oncology2005;23(10):2310‐7. ">Stahl 2005</a>. It showed that there was no survival benefit when esophagectomy was added to chemo‐radiotherapy, similar to the findings of this review. </p> <p>We acknowledge that while there was some overlap between this review and the review by <a href="./references#CD010511-bbs2-0007" title="BestLMJ , MughalM , GurusamyKS . Non‐surgical versus surgical treatment for oesophageal cancer. Cochrane Database of Systematic Reviews2016, Issue 3. [DOI: 10.1002/14651858.CD011498.pub2] ">Best 2016</a>, there are important differences as well. First, our review's question was more specific, as we were only interested in knowing if there was any clinical benefit for people who had undergone chemoradiotherapy for esophageal cancer if esophagectomy was added, whereas <a href="./references#CD010511-bbs2-0007" title="BestLMJ , MughalM , GurusamyKS . Non‐surgical versus surgical treatment for oesophageal cancer. Cochrane Database of Systematic Reviews2016, Issue 3. [DOI: 10.1002/14651858.CD011498.pub2] ">Best 2016</a> was more interested in comparing the effects of a non‐surgical approach with a surgical approach for treatment of esophageal cancer. The definitions of non‐surgical and surgical approaches in <a href="./references#CD010511-bbs2-0007" title="BestLMJ , MughalM , GurusamyKS . Non‐surgical versus surgical treatment for oesophageal cancer. Cochrane Database of Systematic Reviews2016, Issue 3. [DOI: 10.1002/14651858.CD011498.pub2] ">Best 2016</a> review were extremely varied. Non‐surgical approaches could include radiotherapy alone or chemoradiotherapy treatment, and surgical approaches included esophagectomy alone or esophagectomy plus chemoradiotherapy. Second, we examined the effects of adding esophagectomy to chemoradiotherapy more thoroughly than <a href="./references#CD010511-bbs2-0007" title="BestLMJ , MughalM , GurusamyKS . Non‐surgical versus surgical treatment for oesophageal cancer. Cochrane Database of Systematic Reviews2016, Issue 3. [DOI: 10.1002/14651858.CD011498.pub2] ">Best 2016</a>, who only pooled the effects of adding esophagectomy for overall survival. Besides overall survival, we also pooled the effects of additional esophagectomy on freedom from locoregional relapse, and treatment‐related mortality. </p> <p>In addition, prospective non‐randomized studies corroborated our findings. <a href="./references#CD010511-bbs2-0005" title="WangH , RyuJ , GandaraD , BoldR , UrayamaS , TanakaM , et al. A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. Journal of Thoracic Oncology2007;2(2):153‐7. ">Wang 2007</a> conducted a prospective non‐randomized study comprising 50 participants with esophageal cancer, 67% of whom had adenocarcinoma histology, and comparing carboplatin and paclitaxel and radiotherapy to 45 Gy, followed by esophagectomy versus carboplatin and paclitaxel and radiotherapy to 50.4 Gy, followed by consolidation chemotherapy alone. The survival outcomes were not difference between the two groups (three‐year survival 60% in each group). A single institution retrospective series similarly found no difference in survival outcomes with the addition of surgery (<a href="./references#CD010511-bbs2-0040" title="RawatS , KumarG , KakriaA , SharmaMK , ChauhanD . Chemoradiotherapy in the management of locally advanced squamous cell carcinoma esophagus: Is surgical resection required?. Journal of Gastrointestinal Cancer2013;44:277‐84. ">Rawat 2013</a>). </p> <p>Both of our included studies were conducted in the 1990’s, therefore one has to re‐examine the effect of increased treatment‐related mortality with esophagectomy, which may have negated any potential survival advantage (<a href="./references#CD010511-bbs2-0020" title="FinksJ , OsborneN , BirkmeyerJ . Trends in hospital volume and operative mortality for high‐risk surgery. New England Journal Of Medicine2011;364:2128‐37. ">Finks 2011</a>; <a href="./references#CD010511-bbs2-0024" title="JafariMD , HalabiWJ , SmithBR , NguyenVQ , PhelanMJ , StamosMJ , et al. A decade analysis of trends and outcomes of partial versus total esophagectomy in the United States. Annals of Surgery2013;258:450‐8. ">Jafari 2013</a>). Could there be a potential survival benefit with improved modern surgical techniques and post‐operative care? As such, the applicability of these results to modern day treatment techniques (surgery, radiotherapy) may be questioned. </p> <p>Practice guidelines from <a href="http:///www.nccn.org" target="_blank">NCCN</a> (Version 3.2015) are in line with our findings. These guidelines recommend surveillance in people with SCC undergoing definitive chemoradiation, unless there is evidence of persistent local disease, for which salvage esophagectomy should be undertaken. Similarly, ESMO guidelines recommend either chemoradiation with planned surgery, or close surveillance with salvage surgery, for people with locally advanced SCC (<a href="./references#CD010511-bbs2-0046" title="StahlM , MarietteC , HaustermansK , CervantesA , ArnoldD . Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Annals of Oncology2013;24:51‐6. ">Stahl 2013</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010511-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/urn:x-wiley:14651858:media:CD010511:CD010511-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_t/tCD010511-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010511-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010511-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/urn:x-wiley:14651858:media:CD010511:CD010511-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_t/tCD010511-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow diagram." data-id="CD010511-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>PRISMA flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010511-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/urn:x-wiley:14651858:media:CD010511:CD010511-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_t/tCD010511-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone, Outcome 1 Overall survival." data-id="CD010511-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone, Outcome 1 Overall survival. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/references#CD010511-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010511-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/urn:x-wiley:14651858:media:CD010511:CD010511-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_t/tCD010511-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone, Outcome 2 Freedom from locoregional relapse." data-id="CD010511-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone, Outcome 2 Freedom from locoregional relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/references#CD010511-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010511-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/urn:x-wiley:14651858:media:CD010511:CD010511-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_t/tCD010511-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone, Outcome 3 Quality of Life (at 3 months)." data-id="CD010511-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone, Outcome 3 Quality of Life (at 3 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/references#CD010511-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010511-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/urn:x-wiley:14651858:media:CD010511:CD010511-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_t/tCD010511-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone, Outcome 4 Treatment‐related mortality." data-id="CD010511-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone, Outcome 4 Treatment‐related mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/references#CD010511-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010511-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/urn:x-wiley:14651858:media:CD010511:CD010511-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_t/tCD010511-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone, Outcome 5 Use of salvage procedures for dysphagia." data-id="CD010511-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone, Outcome 5 Use of salvage procedures for dysphagia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/references#CD010511-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/media/CDSR/CD010511/image_n/nCD010511-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010511-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer</span></div> <tbody> <tr class="table-header separated"> <td align="left" class="table-header" colspan="6" rowspan="1" valign="top"> <p><b>Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> nonmetastatic esophageal cancer<br/> <b>Setting:</b> hospital<br/> <b>Intervention:</b> chemoradiotherapy plus surgery<br/> <b>Comparison:</b> chemoradiotherapy alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b> Relative effect (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with chemoradiotherapy alone</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with chemoradiotherapy plus surgery</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overall survival<br/> Follow‐up: median 4 to 6 years </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35.4% to 40.0% at 2 years</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34.0% to 39.9% at 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 0.99 (95% CI 0.79 to 1.24)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> High </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Freedom from locoregional relapse</p> <p>Follow‐up: median 4 to 6 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40.7% to 57.0% at 2 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>64.3% to 66.4% at 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HR 0.55 (95% CI 0.39 to 0.76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431<br/> (2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> Moderate<sup>1</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of Life</p> <p>assessed with: Spitzer QoL index</p> <p>Scale: 0 to10</p> <p>Follow‐up: 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>the mean Q0L score was 7.52 points in the chemoradiotherapy alone group</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>the mean QoL score in the chemoradiotherapy plus surgery group was 0.93 points worse (from ‐1.62 worse to ‐0.24 worse) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>165</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very Low<sup>2,3,4</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Treatment‐related mortality</p> <p>Follow‐up: median 1 to 3 months</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1.9 per 100</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9.5 per 100</p> <p>(3.2 to 27.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 5.11<br/> (95% CI 1.74 to 15.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Use of salvage procedures for dysphagia</p> <p>Follow‐up: median 4 years</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>46 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.52 (95% CI 0.36 to 0.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>259</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>HR:</b> Hazard ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to risk of bias (detection bias as investigators were not blinded).<br/> <sup>2</sup> Downgraded one level due to imprecision.<br/> <sup>3</sup> Downgraded two levels due to risk of bias (detection bias as investigators and participants were not blinded). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/full#CD010511-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010511-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall survival <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.79, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Freedom from locoregional relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.39, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Quality of Life (at 3 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Treatment‐related mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.11 [1.74, 15.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Use of salvage procedures for dysphagia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Chemoradiotherapy (CRT) plus surgery versus chemoradiotherapy alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010511.pub2/references#CD010511-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010511.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010511-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010511-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD010511-note-0002">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD010511-note-0001">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010511-note-0007">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010511\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010511\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010511\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010511\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010511\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010511.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010511.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010511.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010511.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010511.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718687850"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010511.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718687854"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010511.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd66fbc84f47a',t:'MTc0MDcxODY4OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 